Top Medical News from Across Medscape

  • AAFP Declines to Endorse New 130/80 BP Treatment GuidelinesIt will stick with the higher-threshold 2014 Eighth Joint National Committee guidelines. AAFP cites concerns about methodology and perceived conflicts of interest with the AHA/ACC recommendation.
  • FDA OKs Eskata for Raised Seborrheic KeratosesEskata is a proprietary, high-concentration hydrogen peroxide-based topical solution applied by a healthcare provider directly to raised seborrheic keratoses using a penlike applicator.
  • Cutting Carbon Emissions in Healthcare: Target the ORAddressing climate change in healthcare should target the operating theater, which has a large carbon footprint, mostly as a result of the use of anesthetic gases and energy demands, a study found.

Special Report

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California